|
|
| | 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine Basic information |
| Product Name: | 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine | | Synonyms: | 5-Bromo-4-chloro-N-cyclopentylpyrimidin-2-amineQ: What is
5-Bromo-4-chloro-N-cyclopentylpyrimidin-2-amine Q: What is the CAS Number of
5-Bromo-4-chloro-N-cyclopentylpyrimidin-2-amine;2-Pyrimidinamine, 5-bromo-4-chloro-N-cyclopentyl-;Palbociclib impurity 3/5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine;Palbociclib-001;5-Bromo-4-chloro-N-cyclopentylpyrimidin-2-amine | | CAS: | 1823404-28-9 | | MF: | C9H11BrClN3 | | MW: | 276.56 | | EINECS: | | | Product Categories: | | | Mol File: | 1823404-28-9.mol |  |
| | 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine Chemical Properties |
| Boiling point | 398.2±45.0 °C(Predicted) | | density | 1.643±0.06 g/cm3(Predicted) | | pka | 1.87±0.10(Predicted) |
| | 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine Usage And Synthesis |
| Uses | 5-?Bromo-?4-?chloro-?N-?cyclopentylpyrimidin?-?2-?amine is an impurity of Palbociclib (P139900), (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| | 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine Preparation Products And Raw materials |
|